Peptide Drugs intermediate
GLP-1 and CKD
Renal outcomes data including albuminuria reduction and eGFR preservation in chronic kidney disease.
By Encyclopeptide Editorial | 1 min read
glp1 ckd kidney
GLP-1 and CKD
Overview
Renal outcomes data including albuminuria reduction and eGFR preservation in chronic kidney disease.
Structure
| Property | Value |
|---|---|
| Name | GLP-1 and CKD |
Mechanism of Action
GLP-1 agonists reduce albuminuria and slow eGFR decline independent of glucose lowering.
References
- Wikipept Peptide Database
- Primary literature (see individual entries)
Chemical Identity
| Property | Value |
|---|---|
| Name | GLP-1 and CKD |
| Category | Peptide Drugs |
Test Your Knowledge
Reinforce what you learned about GLP-1 and CKD with interactive quizzes on Wikipept.
Take a Quiz on Wikipept